This site uses modern web standards that aren't supported by your browser. For best results, please upgrade to Google Chrome, Microsoft Edge, or Mozilla Firefox.

Homepage

Intellectual Property Solutions

Customizable, innovative services that span the patent workflow. Prepare, draft, prosecute, defend, monitor and manage with confidence.

Learn More

Life Sciences Solutions

Gain control with offerings that smooth the collection, transformation, submission, management and analysis of medical device and drug product data.

Learn More

Government Solutions

Innovative solutions for data conversion, preservation, analysis, e-submission and publication for corporate, legal and government clients.

Learn More

Featured Resources


/// Intellectual Property
11.15.2016

Commentators have suggested that the explosion in free patent information would come at the expense of commercial vendors and looked forward to a "new democracy in patent searching. Others feared that the rise of the free services would lead to a reduction in quality or among choice of vendors. But does it have to be a case of either/or?

+ Read More
/// Intellectual Property
09.28.2016

The Supreme Court’s decision in Alice v. CLS Bank has significantly altered how patent claims are analyzed by patent examiners for certain art units. The 2014 ruling had lead to a host of new rejections under 35 U.S.C. §101 in the past several years, particularly in art units under tech center 3600.

+ Read More
/// Life Sciences
09.19.2016

Jeff Peacock, VP of Global Quality Assurance and Regulatory Affairs at Henry Schein, gives industry members an overview of how his organization approached the challenge of UDI data submission to FDA.

+ Read More
/// Intellectual Property
/// Intellectual Property
/// Life Sciences
11.15.2016

Commentators have suggested that the explosion in free patent information would come at the expense of commercial vendors and looked forward to a "new democracy in patent searching. Others feared that the rise of the free services would lead to a reduction in quality or among choice of vendors. But does it have to be a case of either/or?

09.28.2016

The Supreme Court’s decision in Alice v. CLS Bank has significantly altered how patent claims are analyzed by patent examiners for certain art units. The 2014 ruling had lead to a host of new rejections under 35 U.S.C. §101 in the past several years, particularly in art units under tech center 3600.

09.19.2016

Jeff Peacock, VP of Global Quality Assurance and Regulatory Affairs at Henry Schein, gives industry members an overview of how his organization approached the challenge of UDI data submission to FDA.

Number of utility patents processed by Reed Tech to date:


0

as of November 1, 2016

binary options south africa